Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report)’s share price traded down 17.9% during trading on Monday . The stock traded as low as $8.95 and last traded at $8.95. 150 shares changed hands during trading, a decline of 99% from the average session volume of 11,323 shares. The stock had previously closed at $10.90.
Oxford BioMedica Trading Up 6.5%
The company has a current ratio of 1.89, a quick ratio of 1.67 and a debt-to-equity ratio of 3.08. The stock’s fifty day moving average is $10.50 and its 200-day moving average is $8.86.
About Oxford BioMedica
Oxford BioMedica is a clinical-stage gene and cell therapy company headquartered in Oxford, United Kingdom. The company specializes in the development, manufacturing and commercialization of lentiviral vector delivery systems for use in treating serious diseases. Its proprietary LentiVector® platform underpins both in-house development programs and third-party collaborations, enabling the stable integration of therapeutic genes into target cells.
In its research pipeline, Oxford BioMedica is advancing candidates across ophthalmology, neuroscience and oncology indications.
Read More
- Five stocks we like better than Oxford BioMedica
- 3 Signs You May Want to Switch Financial Advisors
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
- Where to invest $1,000 right now
- Your Bank Account Is No Longer Safe
- REVEALED: Something Big Happening Behind White House Doors
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.
